Screener
Emergent Biosolutions EBS Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Emergent Biosolutions’s 10-Q, filed August 6, 2026.
- Filed
- Aug 5, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001367644-26-000082
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Amortization of intangible assets | 17.2 | 16.2 | 33.7 | 32.5 |
| Impairment of long-lived assets | 191.3 | — | 191.3 | — |
| Total operating expenses | 359.4 | 139.3 | 505.0 | 311.6 |
| Income (loss) from operations | (125.1) | 1.6 | (114.6) | 51.5 |
| Other income (expense): | ||||
| Interest expense | (10.0) | (14.7) | (21.0) | (29.4) |
| Loss on assets held-for-sale | (10.7) | — | (10.7) | (12.2) |
| Loss on debt extinguishment | (20.5) | — | (20.5) | — |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Emergent Biosolutions's operating income?
- Emergent Biosolutions (EBS) reported operating income of -$125.1M in Q2 2026.
- How has Emergent Biosolutions's operating income changed year-over-year?
- Emergent Biosolutions's operating income decreased by 7918.8% year-over-year, from $1.6M to -$125.1M.
- What is the long-term trend for Emergent Biosolutions's operating income?
- Over 3 years (2021 to 2024), Emergent Biosolutions's operating income has grown at a -31.7% compound annual growth rate (CAGR), from $341.4M to -$108.7M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about Emergent Biosolutions's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude